DSM completes acquisition of Erber Group
OVERLAND PARK, KS (Oct 5, 2020) – Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announces the completion of its acquisition of Erber Group’s Biomin and Romer Labs for an enterprise value of €980 million. The transaction, first announced on June 12th, forecasts enhanced earnings in the first year upon completion.
Biomin, a specialty animal nutrition and health business, specializes primarily in mycotoxin risk management and gut health performance. The acquisition of Biomin further strengthens DSM’s expertise and reputation as a leading provider of animal health and nutrition solutions for farm productivity and sustainability, with an emphasis on emissions reduction, feed consumption efficiency, and better use of water and land. It is therefore aligned closely with DSM’s focus to make animal farming more sustainable from both an ecological and economical perspective.
The Romer Labs business focuses on food and feed safety diagnostic solutions. Romer Labs also complements DSM’s human nutrition and health offering to customers in the food & beverage market segments. Both entities expand DSM’s range of higher value-add specialty solutions.
DSM – Bright Science. Brighter Living.™
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
For additional information on the news that is the subject of this release, contact firstname.lastname@example.org
BIOMIN, part of Erber Group, is a leading research company and producer of feed additives in the poultry, swine, and ruminant markets, operating in over 120 countries. Well-known for closely examining and identifying mycotoxins, BIOMIN offers sophisticated technologies to deliver natural and profitable solutions. BIOMIN experts also partner with customers to explore gut health challenges and offers a line of products in the phytogenics, probiotics, organic acids, and yeast categories. For the past 30 years, BIOMIN has been committed to pioneering solutions that will help maximize animal health and performance. www.biomin.net/us